NCT03589586View on ClinicalTrials.gov

Clinical Effectiveness of DermACELL AWM in Subjects With Chronic Venous Leg Ulcers

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 25, 2018

Primary Completion Date

January 15, 2021

Study Completion Date

March 15, 2021

Conditions
Venous Leg Ulcer
Interventions
OTHER

DermACELL AWM

DermACELL AWM is a sterile, ready to use acellular dermal matrix

Trial Locations (7)

27804

Purvis Moyer Foot and Ankle Center, Rocky Mount

33143

Doctors Research Network, South Miami

33442

South Florida Podiatry, Deerfield Beach

85710

Arizona Regional Medical Research, Tucson

85723

Southern Arizona VA Health Care System Department of Podiatry, Tucson

90057

LA Foot and Ankle Clinic, Los Angeles

93710

Limb Preservation Platform, Fresno

Sponsors

Lead Sponsor

LifeNet Health
All Listed Sponsors
lead

LifeNet Health

INDUSTRY

NCT03589586 - Clinical Effectiveness of DermACELL AWM in Subjects With Chronic Venous Leg Ulcers | Biotech Hunter | Biotech Hunter